The authors noted that right-sided EA is often misdiagnosed as acute appendicitis, and that steady but sharp and nonmigratory pain in either of the lower abdominal quadrants should raise suspicion of EA.
Epiploic appendagitis may be causing that abdominal pain | Image Credit: Contemporary Pediatrics
In a recent case report, a group of physicians in India describe an 11-year-old boy who came to their hospital’s emergency department with acute onset, constant sharp abdominal pain localized to the right lower quadrant. An ultrasound indicated a normal appendix despite probe tenderness, whereas CT showed an oval fat-attenuated lesion on the right antimesenteric border of the colon, which is characteristic of epiploic appendagitis (EA). The patient was prescribed ibuprofen and antiemetics and experienced complete remission of symptoms. He remained asymptomatic at 2 weeks follow-up.
The authors noted that right-sided EA is often misdiagnosed as acute appendicitis, and that steady but sharp and nonmigratory pain in either of the lower abdominal quadrants should raise suspicion of EA. Although ultrasonography is the diagnostic entity of choice, its sensitivity is low and it is operator dependent. As a result, abdominal CT, with its potential for pathognomonic findings, is the most widely used imaging tool for EA.
This condition is new to me. Add this to mesenteric adenitis, among others, in your differential of acute right-lower abdominal pain, and you may be able to spare some children from exploratory surgery—albeit at the cost of a CT scan—when the ultrasound is inconclusive.
For more from the August, 2023 issue of Contemporary Pediatrics®, click here.
Reference:
Rustogi D, Khare C, Kumar K. Epiploic appendagitis: not so unusual cause of pediatric abdominal pain. Int J Pediatr Adolesc Med.2022;9(4):225-226. doi:10.1016/j.ijpam.2023.01.001
Pediatric cancer survivors and cardiovascular toxicity, disease risk
March 21st 2025Pediatric cancer survivors can be vulnerable to cardiovascular disease in the short- or long-term with increased recognition of cardiotoxic cancer treatments, as 5-year survival rates for children are greater than 85%.